CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies

Blood

Volumn 88, Issue 8, 1996, Pages 3223-3229

  Mavroudis, Dimitrios ^a   Read, Elizabeth ^b   Cottler Fox, Michele ^b   Couriel, Daniel ^b   Molldrem, Jeffrey ^b   Carter, Charles ^b   Yu, Monica ^b   Dunbar, Cynthia ^b   Barrett, John ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ALLOGENEIC RESTRICTION; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CLINICAL ARTICLE; DOSE RESPONSE; ERYTHROCYTE TRANSFUSION; FOLLOW UP; HLA SYSTEM; HUMAN; MALIGNANT TRANSFORMATION; MORBIDITY; MYELODYSPLASTIC SYNDROME; PREDICTION; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS; SCHOOL CHILD;

EID: 0029859287     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.8.3223.bloodjournal8883223     Document Type: Article

References (24)

1. Gengozian N, Makinodan T: Mortality of mice as affected by variation of the X-ray dose and number of nucleated rat bone marrow cells injected. Cancer Res 17:970, 1957
2. Uharek L, Gassmann W, Glass B, Steinmann J, Loeffler H, Mueller-Ruchholtz W: Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation. Blood 79.1612, 1992
3. Arnold R, Schmeiser T, Heit W, Frickhofen N, Pabst G, Heimpel H, Kubanek B: Hemopoietic reconstitution after bone marrow transplantation. Exp Hematol 14:271, 1986
4. To LB, Roberts MM, Haylock DN, Dyson PG, Branford AL, Thorp D, Ho JQK, Dart GW, Horvath N, Davy MLJ, Olweny CLM, Abdi E, Juttner CA: Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 9:277, 1992
5. Torres A, Alonso MC, Gomez-Villagran JL, Manzanares MR, Martinez F, Gomez P, Garcia JM, Andres P, Gomez C, Torre MA, Velasco F: No influence of number of donor CFU-GM on granulocyte recovery in bone marrow transplantation for acute leukemia. Blut 50:89, 1985
6. Atkinson K, Norrie S, Chan P, Downs K, Biggs J: Lack of correlation between nucleated bone marrow cell dose, marrow CFU-GM dose or marrow CFU-E and the rate of HLA-identical sibling marrow engraftment. Br J Haematol 60:245, 1985
7. Bacigalupo A, Piaggio G, Podesta M, Figari O, Benvenuto F, Sogno G, Tedone E, Raffo MR, Grassia L, Ferrero R, van Lint MT, Gualandi F: Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation. Bone Marrow Transplant 15:221, 1995
8. Roscoe RA, Rybka WB, Winkelstein A, Houston AM, Kiss JE: Enumeration of CD34+ hematopoietic stem cells for reconstitution following myeloablative therapy. Cytometry 16:74, 1994
9. Weaver C, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W: An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86:3961, 1995
10. Bensinger WI, Longin K, Appelbaum F, Rowley S, Weaver C, Lilleby K, Gooley T, Lynch M, Higano T, Klarnet J, Chauncey T, Storb R, Buckner CD: Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 87:825, 1994
11. dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 86:2842, 1995
12. Quinones R, Gutierrez R, Dinndorf P, Gress R, Ney A, Taylor B, Karandish S, Carter C, Luban N, Reaman G: Extended-cycle elutriation to adjust T-cell content in HLA-disparate bone marrow transplantation. Blood 82:307, 1993
13. Couriel D, Cottler-Fox M, Burt RK, Dunbar C, Hensel N, Young NS, Barrett AJ: T-cell depleted marrow transplants with delayed lymphocyte add-back to prevent relapse in patients with leukemia and MDS. Blood 84:334a, 1994 (abstr, suppl 1)
14. Yu M, Cottler-Fox M: Quality assurance in flow cytometry: Comparison of three methods for quantifying CD34- cells in marrow. Prog Clin Biol Res 389:729, 1994
15. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
16. Peto R, Peto J: Asymptomatically efficient rank invariant procedures. J R Stat Soc 135:185, 1972
17. Silvestri F, Banavali S, Baccarani M, Preisler H: The CD34 hemopoietic progenitor cell associated antigen: Biology and clinical applications. Haematologica 77:265, 1992
18. Fritsch G, Emminger W, Buchinger P, Printz D, Gadner H: CD34-positive cell proportions in peripheral blood correlate with colony-forming capacity. Exp Hematol 19:1079, 1991
19. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C, Reginald C, Chauncey T, Klarnet J, Montgomery P, Petersdorf S, Weiden P, Witherspoon R, Buckner C: Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 13:2547, 1995
20. Gordon MY, Blackett NM: Some factors determining the minimum number of cells required for successful clinical engraftment. Bone Marrow Transplant 15:659, 1995
21. Daley J, Rozans M, Smith B, Burakoff S, Rappeport J, Miller R: Retarded recovery of functional T cell frequencies in T cell-depleted bone marrow transplant recipients. Blood 70:960, 1987
22. Hertenstein B, Hampl WD, Wiesneth M, Duncker C, Koszinowski U, Heimpel H, Arnold R, Mertens T: In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT. Bone Marrow Transplant 15:387, 1995
23. Lane T, Law P, Maruyama M, Young D, Burgess J, Mullen M, Meleiffe M, Terstappen L, Hardwick A, Moubayed M, Oldham F, Corringham R, Ho A: Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony stimulating factor (GM-CSF) or G-CSF: Potential role in allogeneic marrow transplantation. Blood 85:275, 1995
24. + blood cells. Blood 86:2500, 1995